Trials / Completed
CompletedNCT04247828
Adaptive and Individualized AAC
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Altec Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.
Detailed description
The diversity of the more than 1.3% of Americans who suffer from severe physical impairments (SPIs) preclude the use of common augmentative or alternative communication (AAC) solutions such as manual signs, gestures or interaction with a touchscreen for communication. This clinical trial will test the feasibility of developing a smart-AAC system designed using individually adaptive access methods and AAC interfaces to accommodate the unique manifestations of motor impairments specific to each user. The investigators will demonstrate the proof-of-concept that a single surface electromyographic (sEMG) and inertial measurement unit (IMU) hybrid sensor worn on the forehead can provide improvements in information transfer rate (ITR) and communication accuracy when integrated with an AAC interface that is optimized compared to a conventional (non-adaptable) interface for subjects with SPI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Experimental AAC | Participant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with an adaptive and individualized keyboard to test communication performance. |
| DEVICE | Generic AAC | Participant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with a generic QWERTY keyboard to test communication performance. |
Timeline
- Start date
- 2020-01-06
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
- First posted
- 2020-01-30
- Last updated
- 2022-04-06
- Results posted
- 2022-04-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04247828. Inclusion in this directory is not an endorsement.